Fresenius Kabi has launched its denosumab biosimilars Conexxence® and Bomyntra® across Europe following European Commission approval in July 2025 for all indications of their reference medicines ...
Sampaio, A. , Figueiras, J. and Gomes, A. (2025) BIM Applied to Bridges: Single-Cell Box Deck Modelling Supported by Dynamo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback